Degree in Biomedical Engineering
Degree in Chemical Engineering
Degree in Computational Biology
Bioinformatics, Drug Discovery, Effective communication skills, Machine learning techniques, Molecular biology
Our Biotherapeutics and Medicinal Sciences department is seeking a highly motivated PhD scientist to develop Machine Learning (ML) and/or bioinformatics methods to aid drug discovery across four therapeutic modalities - biologics, gene therapy/viral delivery, small molecules or antisense oligonucleotides. Working in our Biologics Structure and Modeling group, you will collaborate closely with our Antibody Discovery group on integrating ML and computational protein modeling/design with wet-lab experiments at various throughput levels. The Research Fellow role at Biogen is an 18-month position designed to provide a unique opportunity for scientists to gain exposure to drug discovery and train in an industry research setting.
What you will do:
Requirements:
About us
Biologics Structure and Modeling is a highly cross-functional team that primarily supports Biologics Drug Discovery by solving protein apo and complex structures (cryo-EM, X-ray crystallography, NMR), by computationally or rationally modeling, engineering, or designing biologics, and by advising our stakeholders on structural aspects of protein-protein interactions and how mutations affect biology. Beyond Biologics Drug Discovery, and as part of a four-modality company, we partner with colleagues in gene therapy, computational chemistry, and computational biology, supporting Biogen portfolio programs across all therapeutic areas including Alzheimer’s disease and dementia, Parkinson’s disease, Amyotrophic lateral sclerosis (ALS) and multiple sclerosis.
Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.
Baar, Switzerland
6-8 year